Vascular regeneration: Engineering the stem cell microenvironment

Regenerative Medicine

Volumn 4, Issue 3, 2009, Pages 435-447

  Sun, Guoming ^a   Gerecht, Sharon ^a  

^a Johns Hopkins University   (United States)

Author keywords

Biomaterial; Microenvironment; Regeneration; Scaffolds; Stem cells; Vascular

Indexed keywords

ALGINIC ACID; CHITOSAN; COLLAGEN; DEXTRAN; FIBRIN; HYALURONIC ACID; SCLEROPROTEIN; VASCULOTROPIN;

ANGIOGENESIS; BIOCOMPATIBILITY; BIODEGRADABILITY; BLASTOCYST; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL VIABILITY; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HYDROGEL; MESENCHYMAL STEM CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SILK; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TOPOGRAPHY; VASCULAR DISEASE; BLOOD VESSEL; BONE MARROW CELL; CELL PROLIFERATION; CYTOLOGY; METABOLISM; METHODOLOGY; PHYSIOLOGY; REGENERATION;

BLOOD VESSELS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; EMBRYONIC STEM CELLS; HUMANS; PLURIPOTENT STEM CELLS; REGENERATION; STEM CELLS; TISSUE ENGINEERING; VASCULAR DISEASES;

EID: 68049133061     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/rme.09.1     Document Type: Review

References (140)

1. Sata M, Nagai R: Vascular regeneration and remodeling by circulating progenitor cells. In: Cardiovascular Regeneration Therapies Using Tissue Engineering Approaches. Springer-Verlag, Tokyo 117-127 (2005).
2. Hirsch AT, Criqui MH, Treat-Jacobson D et al.: Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286, 1317-1324 (2001).
3. Srivastava D, Ivey KN: Potential of stem-cell-based therapies for heart disease. Nature 441, 1097-1099 (2006).
4. Adams B, Xiao Q, Xu Q: Stem cell therapy for vascular disease. Trends Cardiovasc. Med. 17, 246-251 (2007).
5. Isner JM, Asahara T: Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J. Clin. Invest. 103, 1231-1236 (1999).
6. Guiducci S, Distler O, Distler JHW, Matucci-Cerinic M: Mechanisms of vascular damage in SSc - implications for vascular treatment strategies. Rheumatology (Oxford) 47, v18-v20 (2008).
7. Wobus AM, Boheler KR: Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol. Rev. 85, 635-678 (2005).
8. Wang L, Li L, Shojaei F et al.: Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity 21, 31-41 (2004).
9. Gerecht-Nir S, Ziskind A, Cohen S, Itskovitz-Eldor J: Human embryonic stem cells as an in vitro model for human vascular development and the induction of vascular differentiation. Lab. Invest. 83, 1811-1820 (2003).
10. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R: Endothelial cells derived from human embryonic stem cells. Proc. Natl Acad. Sci. USA 99, 4391-4396 (2002).
11. Gerecht-Nir S, Dazard JE, Golan-Mashiach M et al.: Vascular gene expression and phenotypic correlation during differentiation of human embryonic stem cells. Dev. Dyn. 232, 487-497 (2005).
12. Ferreira LS, Gerecht S, Fuller J, Shieh HF, Vunjak-Novakovic G, Langer R: Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials 28, 2706-2717 (2007).
13. Kaufman DS, Hanson ET, Lewis RL, Auerbach R, Thomson JA: Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc. Natl Acad. Sci. USA 98, 10716-10721 (2001).
14. + cells: efficient production in the coculture with OP9 stromal cells and ana lysis of lymphohematopoietic potential. Blood 105, 617-626 (2005).
15. Wang ZZ, Au P, Chen T et al.: Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat. Biotechnol. 25, 317-318 (2007).
16. Zambidis ET, Peault B, Park TS, Bunz F, Civin CI: Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood 106, 860-870 (2005).
17. Sone M, Itoh H, Yamahara K et al.: Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Arterioscler. Thromb. Vasc. Biol. 27, 2127-2134 (2007).
18. Cho S-W, Moon S-H, Lee S-H et al.: Improvement of postnatal neovascularization by human embryonic stem cell-derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation 116, 2409-2419 (2007).
19. Lu S-J, Feng Q, Caballero S et al.: Generation of functional hemangioblasts from human embryonic stem cells. Nat. Meth. 4, 501-509 (2007).
20. Izadpanah R, Trygg C, Patel B et al.: Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J. Cell. Biochem. 99, 1285-1297 (2006).
21. Huang NF, Li S: Mesenchymal stem cells for vascular regeneration. Regen. Med. 3, 877-892 (2008).
22. Quarto R, Mastrogiacomo M, Cancedda R et al.: Repair of large bone defects with the use of autologous bone marrow stromal cells. N. Engl. J. Med. 344, 385-386 (2001).
23. Katritsis DG, Sotiropoulou PA, Karvouni E et al.: Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter. Cardiovasc. Interv. 65, 321-329 (2005).
24. Asahara T, Bauters C, Zheng LP et al.: Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92, II365-II371 (1995).
25. Al-Khaldi A, Eliopoulos N, Martineau D, Lejeune L, Lachapelle K, Galipeau J: Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo. Gene Ther. 10, 621-629 (2003).
26. Gruber R, Kandler B, Holzmann P et al.: Bone marrow stromal cells can provide a local environment that favors migration and formation of tubular structures of endothelial cells. Tissue Eng. 11, 896-903 (2005).
27. Chen J, Park HC, Addabbo F et al.: Kidney-derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair. Kidney Int. 74, 879-889 (2008).
28. Gong ZD, Niklason LE: Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J. 22, 1635-1648 (2008).
29. Melero-Martin JM, De Obaldia ME, Kang SY et al.: Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ. Res. 103, 194-202 (2008).
30. Wu Y, Chen L, Scott PG, Tredget EE: Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25, 2648-2659 (2007).
31. Chen L, Tredget EE, Wu PY, Wu Y: Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS ONE 3, e1886 (2008).
32. Yu J, Vodyanik MA, Smuga-Otto K et al.: Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
33. Takahashi K, Tanabe K, Ohnuki M et al.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007).
34. Park IH, Zhao R, West JA et al.: Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141-146 (2008).
35. Schenke-Layland K, Rhodes KE, Angelis E et al.: Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages. Stem Cells 26, 1537-1546 (2008).
36. Mauritz C, Schwanke K, Reppel M et al.: Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118, 507-517 (2008).
37. Delo DM, Olson J, Baptista PM et al.: Non-invasive longitudinal tracking of human amniotic fluid stem cells in the mouse heart. Stem Cells Dev. 17, 1185-1193 (2008).
38. De Coppi P, Bartsch G, Siddiqui MM et al.: Isolation of amniotic stem cell lines with potential for therapy. Nat. Biotech. 25, 100-106 (2007).
39. Murayama T, Asahara T: Bone marrow-derived endothelial progenitor cells for vascular regeneration. Curr. Opin. Mol. Ther. 4, 395-402 (2002).
40. Melero-Martin JM, Khan ZA, Picard A, Wu X, Paruchuri S, Bischoff J: In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 109, 4761-4768 (2007).
41. Stellos K, Gnerlich S, Kraemer B, Lindemann S, Gawaz M: Platelet interaction with progenitor cells: vascular regeneration or injury? Pharmacol. Rep. 60, 101-108 (2008).
42. Shi Q, Rafii S, Wu MH et al.: Evidence for circulating bone marrow-derived endothelial cells. Blood 92, 362-367 (1998).
43. Asahara T, Masuda H, Takahashi T et al.: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85, 221-228 (1999).
44. + cells identifies a population of functional endothelial precursors. Blood 95, 952-958 (2000).
45. Igreja C, Fragoso R, Caiado F et al.: Detailed molecular characterization of cord blood-derived endothelial progenitors. Exp. Hematol. 36, 193-203 (2008).
46. Au P, Daheron LM, Duda DG et al.: Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood 111(3), 1302-1305 (2008).
47. Cherqui S, Kurian SM, Schussler O, Hewel JA, Yates JR 3rd, Salomon DR: Isolation and angiogenesis by endothelial progenitors in the fetal liver. Stem Cells 24, 44-54 (2006).
48. Grenier G, Scime A, Le Grand F et al.: Resident endothelial precursors in muscle, adipose, and dermis contribute to postnatal vasculogenesis. Stem Cells 25, 3101-3110 (2007).
49. Tavian M, Zheng B, Oberlin E et al.: The vascular wall as a source of stem cells. Ann. NY Acad. Sci. 1044, 41-50 (2005).
50. Zengin E, Chalajour F, Gehling UM et al.: Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development 133, 1543-1551 (2006).
51. Ingram DA, Mead LE, Tanaka H et al.: Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104, 2752-2760 (2004).
52. Yoder MC, Mead LE, Prater D et al.: Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109, 1801-1809 (2007).
53. Shin H: Fabrication methods of an engineered microenvironment for ana lysis of cell-biomaterial interactions. Biomaterials 28, 126-133 (2007).
54. Risau W: Mechanisms of angiogenesis. Nature 386, 671-674 (1997).
55. Prior BM, Yang HT, Terjung RL: What makes vessels grow with exercise training? J. Appl. Physiol. 97, 1119-1128 (2004).
56. Ferrara N, Gerber HP, LeCouter J: The biology of VEGF and its receptors. Nat. Med. 9, 669-676 (2003).
57. Fan XJ, Krieg S, Kuo CJ et al.: VEGF blockade inhibits angiogenesis and reepithelialization of endometrium. FASEB J. 22, 3571-3580 (2008).
58. Storkebaum E, Lambrechts D, Carmeliet P: VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 26, 943-954 (2004).
59. Peattie RA, Nayate AP, Firpo MA, Shelby J, Fisher RJ, Prestwich GD: Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants. Biomaterials 25, 2789-2798 (2004).
60. Ehrbar M, Metters A, Zammaretti P, Hubbell JA, Zisch AH: Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. J. Contr. Rel. 101, 93-109 (2005).
61. Koch S, Yao C, Grieb G, Prevel P, Noah EM, Steffens GCM: Enhancing angiogenesis in collagen matrices by covalent incorporation of VEGF. J. Mater. Sci. Mater. Med. 17, 735-741 (2006).
62. Schmidt A, Ladage D, Schinkothe T et al.: Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells 24, 1750-1758 (2006).
63. Edelman ER, Nugent MA, Smith LT, Karnovsky MJ: Basic fibroblast growth-factor enhaces the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries. J. Clin. Invest. 89, 465-473 (1992).
64. Richardson TP, Peters MC, Ennett AB, Mooney DJ: Polymeric system for dual growth factor delivery. Nat. Biotech. 19, 1029-1034 (2001).
65. Chen RR, Silva EA, Yuen WW, Mooney DJ: Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm. Res. 24, 258-264 (2007).
66. Nerem RM: Vascular fluid mechanics, the arterial-wall, and atherosclerosis. J. Biomech. Eng. 114(3), 274-282 (1992).
67. 2+ signaling of vascular endothelial cells: effect of shear-stress and ATP. Am. J. Physiol. 260, H1698-H1707 (1991).
68. De Keulenaer GW, Chappell DC, Ishizaka N, Nerem RM, Alexander RW, Griendling KK: Oscillatory and steady laminar shear stress differentially affect human endothelial redox state - role of a superoxide-producing NADH oxidase. Circ. Res. 82, 1094-1101 (1998).
69. Shyy JY, Chien S: Role of integrins in endothelial mechanosensing of shear stress. Circ. Res. 91, 769-775 (2002).
70. Stone PH, Coskun AU, Kinlay S et al.: Effect of endothelial shear stress on the progression of coronary artery disease, vascular remodeling, and in-stent restenosis in humans - in vivo 6-month follow-up study. Circulation 108, 438-444 (2003).
71. Huang H, Nakayama Y, Qin K et al.: Differentiation from embryonic stem cells to vascular wall cells under in vitro pulsatile flow loading. J. Art. Org. 8, 110-118 (2005).
72. Wang H, Riha GM, Yan S et al.: Shear stress induces endothelial differentiation from a murine embryonic mesenchymal progenitor cell line. Arterioscler. Thromb. Vasc. Biol. 25, 1817-1823 (2005).
73. Illi B, Scopece A, Nanni S et al.: Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress. Circ. Res. 96, 501-508 (2005).
74. Zeng LF, Xiao QZ, Margariti A et al.: HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells. J. Cell Biol. 174, 1059-1069 (2006).
75. Metallo CM, Vodyanik MA, Pablo JJd, Slukvin II, Palecek SP: The response of human embryonic stem cell-derived endothelial cells to shear stress. Biotechnol. Bioeng. 100, 830-837 (2008).
76. Ye C, Bai L, Yan ZQ, Wang YH, Jiang ZL: Shear stress and vascular smooth muscle cells promote endothelial differentiation of endothelial progenitor cells via activation of Akt. Clin. Biomechanics 23, S118-S124 (2008).
77. Kasper G, Dankert N, Tuischer J et al.: Mesenchymal stem cells regulate angiogenesis according to their mechanical environment. Stem Cells 25, 903-910 (2007).
78. Timpl R: Macromolecular organization of basement membranes. Curr. Opin. Cell Biol. 8, 618-624 (1996).
79. Abrams GA, Schaus SS, Goodman SL, Nealey PF, Murphy CJ: Nanoscale topography of the corneal epithelial basement membrane and Descemet's membrane of the human. Cornea 19, 57-64 (2000).
80. Watt FM, Jordan PW, O'Neill CH: Cell shape controls terminal differentiation of human epidermal keratinocytes. Proc. Natl Acad. Sci. USA 85, 5576-5580 (1988).
81. McBeath R, Pirone DM, Nelson CM, Bhadriraju K, Chen CS: Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev. Cell 6, 483-495 (2004).
82. Yim EK, Reano RM, Pang SW, Yee AF, Chen CS, Leong KW: Nanopattern-induced changes in morphology and motility of smooth muscle cells. Biomaterials 26, 5405-5413 (2005).
83. Pasqui D, Rossi A, Barbucci R, Lamponi S, Gerli R, Weber E: Hyaluronan and sulphated hyaluronan micropatterns: effect of chemical and topographic cues on lymphatic endothelial cell alignment and proliferation. Lymphology 38, 50-65 (2005).
84. Rossi A, Pasqui D, Barbucci R, Gerli R, Weber E: The topography of microstructured surfaces differently affects fibrillin deposition by blood and lymphatic endothelial cells in culture. Tissue Eng. A 15(3), 525-533 (2009).
85. Galis ZS, Khatri JJ: Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ. Res. 90, 251-262 (2002).
86. Baluk P, Hashizume H, McDonald DM: Cellular abnormalities of blood vessels as targets in cancer. Curr. Opin. Genet. Dev. 15, 102-111 (2005).
87. Davis GE, Senger DR: Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ. Res. 97, 1093-1107 (2005).
88. Li J, Zhang Y-P, Kirsner RS: Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microsc. Res. Tech. 60, 107-114 (2003).
89. Stupack DG, Cheresh DA, Gerald PS: Integrins and angiogenesis. Curr. Top. Dev. Biol. 64, 207-238 (2004).
90. + cell differentiation into endothelial cells. J. Vasc. Surg. 39, 655-660 (2004).
91. Stupack DG, Cheresh DA: ECM remodeling regulates angiogenesis: endothelial integrins look for new ligands. Sci. STKE 2002(119), PE7 (2002).
92. Silva EA, Kim E-S, Kong HJ, Mooney DJ: Material-based deployment enhances efficacy of endothelial progenitor cells. Proc. Natl Acad. Sci. USA 105, 14347-14352 (2008).
93. Seal BL, Otero TC, Panitch A: Polymeric biomaterials for tissue and organ regeneration. Materials science and engineering. Reports 34, 147-230 (2001).
94. Hutmacher DW: Scaffold design and fabrication technologies for engineering tissues state of the art and future perspectives. J. Biomater. Sci. Polym. Ed. 12, 107-124 (2001).
95. Chen G, Ushida T, Tateishi T: Development of biodegradable porous scaffolds for tissue engineering. Mater. Sci. Eng. C 17, 63-69 (2001).
96. Van Tomme SR, Hennink WE: Biodegradable dextran hydrogels for protein delivery applications. Expert Rev. Med. Dev. 4, 147-164 (2007).
97. Levenberg S, Huang NF, Lavik E, Rogers AB, Itskovitz-Eldor J, Langer R: Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc. Natl Acad. Sci. USA 100, 12741-12746 (2003).
98. Wang GJ, Hsueh CC, Hsu SH, Hung HS: Fabrication of PLGA microvessel scaffolds with circular microchannels using soft lithography. J. Micromech. Microeng. 17, 2000-2005 (2007).
99. Ma ZW, He W, Yong T, Ramakrishna S: Grafting of gelatin on electrospun poly(caprolactone) nanofibers to improve endothelial cell spreading and proliferation and to control cell orientation. Tissue Eng. 11, 1149-1158 (2005).
100. Williamson MR, Woollard KJ, Griffiths HR, Coombes AGA: Gravity spun polycaprolactone fibers for applications in vascular tissue engineering: proliferation and function of human vascular endothelial cells. Tissue Eng. 12, 45-51 (2006).
101. Pankajakshan D, Kalliyana K, Krishnan LK: Vascular tissue generation in response to signaling molecules integrated with a novel poly(-̇caprolactone)-fibrin hybrid scaffold. J. Tissue Eng. Regen. Med. 1, 389-397 (2007).
102. Sarkar S, Lee GY, Wong JY, Desai TA: Development and characterization of a porous micro-patterned scaffold for vascular tissue engineering applications. Biomaterials 27, 4775-4782 (2006).
103. Nijst CLE, Bruggeman JP, Karp JM et al.: Synthesis and characterization of photocurable elastomers from poly(glycerol-co-sebacate). Biomacromolecules 8, 3067-3073 (2007).
104. Gerecht S, Townsend SA, Pressler H et al.: A porous photocurable elastomer for cell encapsulation and culture. Biomaterials 28, 4826-4835 (2007).
105. Davis ME, Motion JPM, Narmoneva DA et al.: Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation 111, 442-450 (2005).
106. Ekaputra AK, Prestwich GD, Cool SM, Hutmacher DW: Combining electrospun scaffolds with electrosprayed hydrogels leads to three-dimensional cellularization of hybrid constructs. Biomacromolecules 9, 2097-2103 (2008).
107. Kidoaki S, Kwon IK, Matsuda T: Mesoscopic spatial designs of nano- and microfiber meshes for tissue-engineering matrix and scaffold based on newly devised multilayering and mixing electrospinning techniques. Biomaterials 26, 37-46 (2005).
108. Zong X, Bien H, Chung C-Y et al.: Electrospun fine-textured scaffolds for heart tissue constructs. Biomaterials 26, 5330-5338 (2005).
109. Yang F, Murugan R, Wang S, Ramakrishna S: Electrospinning of nano/micro scale poly(L-lactic acid) aligned fibers and their potential in neural tissue engineering. Biomaterials 26, 2603-2610 (2005).
110. Yoshimoto H, Shin YM, Terai H, Vacanti JP: A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials 24, 2077-2082 (2003).
111. Jin HJ, Chen JS, Karageorgiou V, Altman GH, Kaplan DL: Human bone marrow stromal cell responses on electrospun silk fibroin mats. Biomaterials 25, 1039-1047 (2004).
112. Soffer L, Wang XY, Mang XH et al.: Silk-based electrospun tubular scaffolds for tissue-engineered vascular grafts. J. Biomater. Sci. Polym. Ed. 19, 653-664 (2008).
113. Jin HJ, Fridrikh SV, Rutledge GC, Kaplan DL: Electrospinning Bombyx mori silk with poly(ethylene oxide). Biomacromolecules 3, 1233-1239 (2002).
114. Matthews JA, Wnek GE, Simpson DG, Bowlin GL: Electrospinning of collagen nanofibers. Biomacromolecules 3, 232-238 (2002).
115. Matthews JA, Boland ED, Wnek GE, Simpson DG, Bowlin GL: Electrospinning of collagen type II: a feasibility study. J. Bioact. Compat. Polym. 18, 125-134 (2003).
116. Shin M, Yoshimoto H, Vacanti JP: In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue Eng. 10, 33-41 (2004).
117. Stankus JJ, Soletti L, Fujimoto K, Hong Y, Vorp DA, Wagner WR: Fabrication of cell microintegrated blood vessel constructs through electrohydrodynamic atomization. Biomaterials 28, 2738-2746 (2007).
118. Thomas V, Zhang X, Catledge SA, Vohra YK: Functionally graded electrospun scaffolds with tunable mechanical properties for vascular tissue regeneration. Biomed. Mater. 2, 224-232 (2007).
119. Jeong SI, Kim SY, Cho SK et al.: Tissue-engineered vascular grafts composed of marine collagen and PLGA fibers using pulsatile perfusion bioreactors. Biomaterials 28, 1115-1122 (2007).
120. Lee SJ, Yoo JJ, Lim GJ, Atala A, Stitze J: In vitro evaluation of electrospun nanofiber scaffolds for vascular graft application. J. Biomed. Mater. Res. A 83A, 999-1008 (2007).
121. Qi HX, Kong SL, Hu P, Zhang J, Lin WJ, Song F: Biomimic tubulose scaffolds with multilayer prepared by electrospinning for tissue engineering. Mater. Sci. Forum 510-511, 882-885 (2006).
122. UNIV NANYANG TECHNOLOGICAL. WO2008069760-A1. Chian KS, Leong MF, Gopal PE, Ratner BD: Three-dimensional hybrid scaffold for tissue engineering comprises porous bioadhesive layer connected to surface of layer of decellularized biological material; and three-dimensional porous polymer scaffold connected to bioadhesive layer (2008).
123. Nicodemus GD, Bryant SJ: Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng. B Rev. 14, 149-165 (2008).
124. Shaikh FM, Callanan A, Kavanagh EG, Burke PE, Grace PA, McGloughlin TM: Fibrin: a natural biodegradable scaffold in vascular tissue engineering. Cells Tissues Organs 188, 333-346 (2008).
125. Seliktar D, Black RA, Vito RP, Nerem RM: Dynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling in vitro. Ann. Biomed. Eng. 28, 351-362 (2000).
126. Yamamoto M, Ikada Y, Tabata Y: Controlled release of growth factors based on biodegradation of gelatin hydrogel. J. Biomater. Sci. Polym. Ed. 12, 77-88 (2001).
127. Ishihara M, Obara K, Ishizuka T et al.: Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization. J. Biomed. Mater. Res. 64(3) 551-559 (2003).
128. Silva EA, Mooney DJ: Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. J. Thromb. Haem. 5, 590-598 (2007).
129. Sun G, Chu C-C: Synthesis, characterization of biodegradable dextran-allyl isocyanate-ethylamine/polyethylene glycol-diacrylate hydrogels and their in vitro release of albumin. Carbohydr. Polym. 65, 273-287 (2006).
130. Stephen P, Massia JS: Immobilized RGD peptides on surface-grafted dextran promote biospecific cell attachment. J. Biomed. Mater. Res. 56, 390-399 (2001).
131. Giavaresi G, Torricelli P, Fornasari PM, Giardino R, Barbucci R, Leone G: Blood vessel formation after soft-tissue implantation of hyaluronanbased hydrogel supplemented with copper ions. Biomaterials 26, 3001-3008 (2005).
132. Slevin M, Krupinski J, Kumar S, Gaffney J: Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab. Invest. 78, 987-1003 (1998).
133. Gerecht S, Burdick JA, Ferreira LS, Townsend SA, Langer R, Vunjak-Novakovic G: Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc. Natl Acad. Sci. USA 104, 11298-11303 (2007).
134. Loebsack A, Greene K, Wyatt S et al.: In vivo characterization of a porous hydrogel material for use as a tissue bulking agent. J. Biomed. Mater. Res. 57, 575-581 (2001).
135. Gerecht-Nir S, Cohen S, Ziskind A, Itskovitz-Eldor J: Three-dimensional porous alginate scaffolds provide a conducive environment for generation of well-vascularized embryoid bodies from human embryonic stem cells. Biotechnol. Bioeng. 88, 313-320 (2004).
136. Moroni L, De Wijn JR, Van Blitterswijk CA: Integrating novel technologies to fabricate smart scaffolds. J. Biomater. Sci. Polym. Ed. 19, 543-572 (2008).
137. Sittinger M, Hutmacher DW, Risbud MV: Current strategies for cell delivery in cartilage and bone regeneration. Curr. Opin. Biotechnol. 15, 411-418 (2004).
138. Chenite A, Chaput C, Wang D et al.: Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 21, 2155-2161 (2000).
139. Petit-Zeman S: Regenerative medicine. Nat. Biotech. 19, 201-206 (2001).
140. Bettinger CJ, Zhang Z, Gerecht S, Borenstein JT, Langer R: Enhancement of in vitro capillary tube formation by substrate nanotopography. Adv. Mater. 20, 99-103 (2008).